Skip to main content

Table 3 Prediction of pathological complete remission with Ki67, using multiple linear regression analysis (extended final model)

From: Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Characteristic

OR

95% CI

P

pT

   

   1

1

-

-

   2-4

0.34

0.18-0.65

< 0.01

Grading

   

   1-2

1

-

-

   3

2.51

1.41-4.49

< 0.01

Estrogen receptor status

   Negative

1

-

-

   Positive

0.30

0.14-0.63

< 0.01

Progesterone receptor status

   Negative

1

-

-

   Positive

0.50

0.22-1.14

0.10

HER2/neu receptor status

   Negative

1

-

-

   Positive

2.37

1.33-4.22

< 0.01

Ki67

   

   Low

1

-

-

   High

3.51

1.41-10.10

0.01

  1. CI, confidence intervals; OR, odds ratio; pT, pathological tumor stage (TNM classification).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us